[HTML] springer.comFull View

[HTML][HTML] Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & …

SD Silberstein, VL Stauffer, KA Day, S Lipsius… - The Journal of …, 2019 - Springer
Background Patients with high-frequency episodic migraine (HFEM) have a greater disease
burden than those with low-frequency episodic migraine (LFEM). Acute treatment overuse …
被引用次数：58 相关文章
[PDF] academia.edu

[PDF][PDF] Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & …

SD Silberstein, VL Stauffer, KA Day, S Lipsius… - 2019 - academia.edu
Background: Patients with high-frequency episodic migraine (HFEM) have a greater disease
burden than those with low-frequency episodic migraine (LFEM). Acute treatment overuse …
[HTML] nih.gov

[HTML][HTML] Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & …

SD Silberstein, VL Stauffer, KA Day… - The Journal of …, 2019 - ncbi.nlm.nih.gov
Background Patients with high-frequency episodic migraine (HFEM) have a greater disease
burden than those with low-frequency episodic migraine (LFEM). Acute treatment overuse …

Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2)

SD Silberstein, VL Stauffer, KA Day… - The journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Patients with high-frequency episodic migraine (HFEM) have a greater disease
burden than those with low-frequency episodic migraine (LFEM). Acute treatment overuse …

Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2)

SD Silberstein, VL Stauffer, KA Day… - The Journal of …, 2019 - search.proquest.com
Background Patients with high-frequency episodic migraine (HFEM) have a greater disease
burden than those with low-frequency episodic migraine (LFEM). Acute treatment overuse …
[HTML] biomedcentral.com

[HTML][HTML] Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & …

SD Silberstein, VL Stauffer… - The Journal of …, 2019 - thejournalofheadacheandpain …
Patients with high-frequency episodic migraine (HFEM) have a greater disease burden than
those with low-frequency episodic migraine (LFEM). Acute treatment overuse increases the …

Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2).

SD Silberstein, VL Stauffer, KA Day… - The Journal of …, 2019 - europepmc.org
Background Patients with high-frequency episodic migraine (HFEM) have a greater disease
burden than those with low-frequency episodic migraine (LFEM). Acute treatment overuse …

Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2).

SD Silberstein, VL Stauffer, KA Day… - … of Headache & …, 2019 - search.ebscohost.com
Background: Patients with high-frequency episodic migraine (HFEM) have a greater disease
burden than those with low-frequency episodic migraine (LFEM). Acute treatment overuse …

Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2).

SD Silberstein, VL Stauffer, KA Day, S Lipsius… - 2019 - jdc.jefferson.edu
BACKGROUND: Patients with high-frequency episodic migraine (HFEM) have a greater
disease burden than those with low-frequency episodic migraine (LFEM). Acute treatment …
[PDF] core.ac.uk

[PDF][PDF] Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & …

SD Silberstein, VL Stauffer, KA Day, S Lipsius… - 2019 - core.ac.uk
Background: Patients with high-frequency episodic migraine (HFEM) have a greater disease
burden than those with low-frequency episodic migraine (LFEM). Acute treatment overuse …